Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer
- 20 September 2005
- journal article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 8 (4) , 359-363
- https://doi.org/10.1038/sj.pcan.4500835
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidaseProceedings of the National Academy of Sciences, 2005
- Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancerJournal of Cellular Biochemistry, 2003
- Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patientsInternational Journal of Cancer, 2003
- Inhibition of prostate‐specific membrane antigen (PSMA)‐positive tumor growth by vaccination with either full‐length or the C‐terminal end of PSMAInternational Journal of Cancer, 2002
- Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolaseMammalian Genome, 2001
- Affinity Measurements by Band Shift and Competition ELISAPublished by Springer Nature ,2001
- Characterisation and Properties of an Intracellular Lipid‐Binding Protein from the Tapeworm Moniezia expansaEuropean Journal of Biochemistry, 1997
- Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase.Proceedings of the National Academy of Sciences, 1996
- “De Novo” Engineering of Peptide Immunogenic and Antigenic Determinants as Potential VaccinesPublished by Springer Nature ,1994
- Purification and characterization of a rat hepatic acetyltransferase that can metabolize aromatic amine derivativesCarcinogenesis: Integrative Cancer Research, 1993